Cargando…

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively

We use surveillance data to describe influenza A and B virus circulation over two consecutive seasons with excess all-cause mortality in Europe, especially in people aged 60 years and older. Influenza A(H3N2) virus dominated in 2016/17 and B/Yamagata in 2017/18. The latter season was prolonged with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adlhoch, Cornelia, Snacken, René, Melidou, Angeliki, Ionescu, Silviu, Penttinen, Pasi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2018
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883452/ https://www.ncbi.nlm.nih.gov/pubmed/29616611 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.13.18-00146

Ejemplares similares

Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019
por: Segaloff, Hannah, et al.
Publicado: (2019)

High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018
por: Mook, Piers, et al.
Publicado: (2020)

Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017
por: Mollers, Madelief, et al.
Publicado: (2019)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020
por: Högberg, Liselotte Diaz, et al.
Publicado: (2021)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
por: Funk, Tjede, et al.
Publicado: (2021)

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022
por: Ventura-Gabarró, Cèlia, et al.
Publicado: (2023)

Letter to the editor: Just a coincidence? Two severe human cases due to swine influenza (SIV) A(H1N1)v in Europe, October 2016
por: Adlhoch, Cornelia, et al.
Publicado: (2017)

Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015
por: Hollo, V, et al.
Publicado: (2017)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017
por: Vestergaard, Lasse S, et al.
Publicado: (2017)

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
por: Reusken, Chantal B.E.M., et al.
Publicado: (2020)

Avian influenza overview – update on 19 November 2020, EU/EEA and the UK
por: Adlhoch, Cornelia, et al.
Publicado: (2020)

Investigation of an international outbreak of multidrug-resistant monophasic Salmonella Typhimurium associated with chocolate products, EU/EEA and United Kingdom, February to April 2022
por: Larkin, Lesley, et al.
Publicado: (2022)

HIV diagnoses among people born in Ukraine reported by EU/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning
por: Reyes-Urueña, Juliana, et al.
Publicado: (2023)

Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016
por: Broberg, Eeva K, et al.
Publicado: (2018)

Legionnaires’ disease in the EU/EEA*: increasing trend from 2017 to 2019
por: Samuelsson, Jonas, et al.
Publicado: (2023)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021
por: Kinross, Pete, et al.
Publicado: (2022)

Estimation of the number of exposed people during highly pathogenic avian influenza virus outbreaks in EU/EEA countries, October 2016–September 2018
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017
por: Spiteri, G, et al.
Publicado: (2017)

Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Highly pathogenic avian influenza A(H5N8) outbreaks: protection and management of exposed people in Europe, 2014/15 and 2016
por: Adlhoch, Cornelia, et al.
Publicado: (2016)

Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?
por: Paget, John, et al.
Publicado: (2022)

Initial assessment of the COVID-19 vaccination’s impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021
por: Nicolay, Nathalie, et al.
Publicado: (2021)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22
por: Melidou, Angeliki, et al.
Publicado: (2022)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Immunisation Information Systems – useful tools for monitoring vaccination programmes in EU/EEA countries, 2016
por: Derrough, Tarik, et al.
Publicado: (2017)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

Testing indicators to monitor the COVID-19 pandemic
por: Beauté, Julien, et al.
Publicado: (2021)

Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
por: Korsun, N. S., et al.
Publicado: (2019)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

Transmission Network of Measles During the Yamagata Outbreak in Japan, 2017
por: Kobayashi, Tetsuro, et al.
Publicado: (2022)

Healthcare workers’ knowledge, attitudes and behaviours with respect to antibiotics, antibiotic use and antibiotic resistance across 30 EU/EEA countries in 2019
por: Ashiru-Oredope, Diane, et al.
Publicado: (2021)

Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
por: Castilla, Jesús, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_785bp6n02gc4rg4g64dr32dgrv